|
|
|
|
|
| Excipeints Articles |
| Title (Click for Abstract / Details) |
Author |
Issue |
Page |
View/Buy |
| Compounding Pearls -- Wound Care: Base Selection |
Riepl Mike
|
Mar/Apr 2020 |
98-102 |
Buy |
| Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems |
Allen Loyd V Jr
|
Mar/Apr 2020 |
114-118 |
Buy |
| Acetazolamide 25 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
130 |
Buy |
| Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
131 |
Buy |
| Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
133 |
Buy |
| Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Mar/Apr 2020 |
134 |
Buy |
| Propylthiouracil 5 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
135 |
Buy |
| Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
136 |
Buy |
| Terbinafine 25 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
137 |
Buy |
| Topiramate 5 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
138 |
Buy |
| Valsartan 4 mg/mL in Syrup NF |
Allen Loyd V Jr
|
Mar/Apr 2020 |
139 |
Buy |
| Feasibility Study of Asthma Cream |
Kuang Andrew
|
Mar/Apr 2020 |
163-167 |
Buy |
| Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel |
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020 |
168-175 |
Buy |
| Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents |
Allen Loyd V Jr
|
Jan/Feb 2020 |
38-43 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved |
Allen Loyd V Jr
|
Jan/Feb 2020 |
44-50 |
Buy |
| Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives |
Allen Loyd V Jr
|
Nov/Dec 2019 |
472-477 |
Buy |
| Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2019 |
486 |
Buy |
| Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored |
Allen Loyd V Jr
|
Nov/Dec 2019 |
487 |
Buy |
| Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2019 |
488 |
Buy |
| Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2019 |
489 |
Buy |
| Sulfasalazine 100 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Nov/Dec 2019 |
490 |
Buy |
| Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Nov/Dec 2019 |
491 |
Buy |
| Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) |
Allen Loyd V Jr
|
Nov/Dec 2019 |
492 |
Buy |
| Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2019 |
493 |
Buy |
| Verapmail Hydrochloride 50 mg/mL in SyrSpend SF |
Allen Loyd V Jr
|
Nov/Dec 2019 |
494 |
Buy |
| Zonisamide 10 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Nov/Dec 2019 |
495 |
Buy |
| Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? |
Shakshuki Ayah, Agu Remigius U
|
Nov/Dec 2019 |
496-503 |
Buy |
| Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid |
Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
|
Nov/Dec 2019 |
504-510 |
Buy |
| Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt |
Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
|
Nov/Dec 2019 |
519-527 |
Buy |
| Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 |
Zur Eyal
|
Sep/Oct 2019 |
366-375 |
Buy |
| Basics: Excipients Used in Nonsterile Compounding, Part 2 |
Allen Loyd V Jr
|
Sep/Oct 2019 |
393-396 |
Buy |
| Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 |
Zur Eyal
|
Jul/Aug 2019 |
288-293 |
Buy |
| Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing |
Allen Loyd V Jr
|
Jul/Aug 2019 |
299-303 |
Buy |
| Basics: Excipients Used in Nonsterile Compounding, Part 1 |
Allen Loyd V Jr
|
Jul/Aug 2019 |
305-311 |
Buy |
| Basics of Sterile Compounding: Vehicles Used in Sterile Compounding |
Allen Loyd V Jr
|
May/Jun 2019 |
221-228 |
Buy |
| Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations |
Allen Loyd V Jr
|
Mar/Apr 2019 |
135-143 |
Buy |
| Dexamethasone 2 mg/g Topical Paste, Veterinary |
Allen Loyd V Jr
|
Mar/Apr 2019 |
149 |
Buy |
| Orodispersible Film |
Allen Loyd V Jr
|
Jan/Feb 2019 |
59 |
Buy |
| Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle |
Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
|
Jan/Feb 2019 |
65-69 |
Buy |
| Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream |
Shakshuki Ayah, Agu Remigius U
|
Jan/Feb 2019 |
82-87 |
Buy |
| Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review |
Cutaia Kara, Chablani Lipika, Zhao Fang
|
Nov/Dec 2018 |
480-489 |
Buy |
| Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2018 |
492 |
Buy |
| Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2018 |
493 |
Buy |
| Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2018 |
494 |
Buy |
| Hydrocortisone 2 mg/mL in Inorpha Suspension |
Allen Loyd V Jr
|
Nov/Dec 2018 |
495 |
Buy |
| Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions |
Allen Loyd V Jr
|
Nov/Dec 2018 |
496 |
Buy |
| Prednisone 5 mg/mL ir Oral Mix Suspension |
Allen Loyd V Jr
|
Nov/Dec 2018 |
497 |
Buy |
| Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin |
Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
|
Nov/Dec 2018 |
498-503 |
Buy |
| Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) |
Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
|
Nov/Dec 2018 |
504-511 |
Buy |
| Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
|
Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
|
Nov/Dec 2018 |
516-526 |
Buy |
| Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel |
Allen Loyd V Jr
|
Sep/Oct 2018 |
409 |
Buy |
| A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier |
Songkro Sarunyoo, Pengmak Somuredee, Seajung Pornyamol, Maneenuan Duangkhae, Kaewnopparat Nattha
|
Sep/Oct 2018 |
424-432 |
Buy |
| Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding |
Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
|
Sep/Oct 2018 |
433-439 |
Buy |
| Quality Control: Water Activity Considerations for Beyond-use Dates |
Allen Loyd V Jr
|
Jul/Aug 2018 |
288-293 |
Buy |
| Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 |
Allen Loyd V Jr
|
Jul/Aug 2018 |
294-300 |
Buy |
| Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating |
Martin Matt
|
Jul/Aug 2018 |
303-312 |
Buy |
| Anhydrous Medium-chain Triglycerides Gel |
Allen Loyd V Jr
|
Jul/Aug 2018 |
316 |
Buy |
| Pitch Ointment: Applications in Scar and Wound Management |
Kloesel Lawson, Carvalho Maria, Banov Fabiana
|
May/Jun 2018 |
182-188 |
Buy |
| Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 |
Allen Loyd V Jr
|
May/Jun 2018 |
220-228 |
Buy |
| Anhydrous Silicon Base Topical Gel Vehicle |
Allen Loyd V Jr
|
May/Jun 2018 |
232 |
Buy |
| Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations |
Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J
|
May/Jun 2018 |
247-251 |
Buy |
| Basics of Compounding: Compounding Microemulsions |
Allen Loyd V Jr
|
Mar/Apr 2018 |
137-143 |
Buy |
| Clonidine Hydrochloride 10 mg/mL in Inorpha Solution |
Allen Loyd V Jr
|
Mar/Apr 2018 |
146 |
Buy |
| The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions |
Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
|
Mar/Apr 2018 |
164-171 |
Buy |
| Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension |
Allen Loyd V Jr
|
Jan/Feb 2018 |
51 |
Buy |
| Metronidazole 50 mg/mL in Ora-Blend Suspension |
Allen Loyd V Jr
|
Jan/Feb 2018 |
52 |
Buy |
| Miconazole 10% in Recura Topical Cream |
Allen Loyd V Jr
|
Jan/Feb 2018 |
53 |
Buy |
| Naproxen 25 mg/mL in Oral Mix or Oral Mix SF |
Allen Loyd V Jr
|
Jan/Feb 2018 |
54 |
Buy |
| Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Jan/Feb 2018 |
55 |
Buy |
| Ranitidine 15 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Jan/Feb 2018 |
56 |
Buy |
| Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension |
Allen Loyd V Jr
|
Jan/Feb 2018 |
58 |
Buy |
| Voriconazole 40-mg/mL Oral Suspension |
Allen Loyd V Jr
|
Jan/Feb 2018 |
59 |
Buy |
| Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing |
Song Guiyun, Banov Daniel, Bassani August S
|
Jan/Feb 2018 |
60-65 |
Buy |
| Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension |
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018 |
66-75 |
Buy |
| Feline Transdermal Formulation Considerations |
Forsythe Lauren Eichstadt
|
Nov/Dec 2017 |
446-452 |
Buy |
| Orodispersible Films for Compounding Pharmacies |
Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2017 |
454-461 |
Buy |
| Basics of Compounding: Hot Melt Extrusion |
DePasquale Seth
|
Nov/Dec 2017 |
471-479 |
Buy |
| Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension |
Allen Loyd V Jr
|
Nov/Dec 2017 |
490 |
Buy |
| To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid |
Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
|
Nov/Dec 2017 |
500-512 |
Buy |
| Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives |
Trimble John O, Light Bob
|
Nov/Dec 2017 |
530-535 |
Buy |
| Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension |
Allen Loyd V Jr
|
Sep/Oct 2017 |
409 |
Buy |
| Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) |
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017 |
418-425 |
Buy |
| Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt |
Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Sep/Oct 2017 |
430-435 |
Buy |
| Component Selection for Sterile Compounding |
Dilzer Richard H
|
Jul/Aug 2017 |
277-280 |
Buy |
| Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future |
Allen Loyd V Jr
|
Jul/Aug 2017 |
293-298 |
Buy |
| Basics of Sterile Compounding: Excipients Used in Injections |
Akers Michael J
|
Jul/Aug 2017 |
301-308 |
Buy |
| Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) |
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017 |
322-329 |
Buy |
| Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt |
Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Jul/Aug 2017 |
334-338 |
Buy |
| Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 |
de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
|
Jul/Aug 2017 |
339-346 |
Buy |
| Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report |
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017 |
205-211 |
Buy |
| Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2 |
Allen Loyd V Jr
|
May/Jun 2017 |
215-220 |
Buy |
| Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil |
Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
|
May/Jun 2017 |
240-241 |
Buy |
| Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions |
de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
|
May/Jun 2017 |
255-263 |
Buy |
| Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students |
Benischek Rita
|
Mar/Apr 2017 |
105-108 |
Buy |
| Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date |
Gautam Pradeep, Light Bob, Purvis Troy
|
Mar/Apr 2017 |
154-159 |
Buy |
| Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions |
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017 |
160-163 |
Buy |
| Basics of Compounding with Dilutions and Concentrates |
Allen Loyd V Jr
|
Jan/Feb 2017 |
39-45 |
Buy |
| Basics of Compounding: Clinical Pharmaceutics, Part 2 |
Allen Loyd V Jr
|
Nov/Dec 2016 |
485-493 |
Buy |
| PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution |
Rost Erika
|
Nov/Dec 2016 |
526-527 |
Buy |
| Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy |
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016 |
367-374 |
Buy |
| Basics of Compounding: Clinical Pharmaceutics, Part 1 |
Allen Loyd V Jr
|
Sep/Oct 2016 |
389-396 |
Buy |
| Tromethamine Injection |
Allen Loyd V Jr
|
Sep/Oct 2016 |
415 |
Buy |
| Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt |
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
|
Sep/Oct 2016 |
421-425 |
Buy |
| Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions |
Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
|
Sep/Oct 2016 |
426-434 |
Buy |
| Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light |
Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
|
Sep/Oct 2016 |
435-437 |
Buy |
| Case Report: Pediatric Scar Management After Open-heart Surgery |
Phan Ha, Harger Beau, Estrada Nick
|
Jul/Aug 2016 |
277-280 |
Buy |
| Basics of Compounding: Compounding Films |
Allen Loyd V Jr
|
Jul/Aug 2016 |
298-305 |
Buy |
| Stability of Ampicillin in Normal Saline and Buffered Normal Saline |
Maher Moureddine, Jensen Kara J, Lee David, Nix David E
|
Jul/Aug 2016 |
338-342 |
Buy |
| Basics of Compounding: Special Capsules |
Allen Loyd V Jr
|
May/Jun 2016 |
209-214 |
Buy |
| Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives |
Trimble John, Light Bob
|
May/Jun 2016 |
250-256 |
Buy |
| Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children |
Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
|
May/Jun 2016 |
257-261 |
Buy |
| Basics of Compounding: Capsules |
Allen Loyd V Jr
|
Mar/Apr 2016 |
125-134 |
Buy |
| Formulation and Stability of Solutions |
Akers Michael J
|
Mar/Apr 2016 |
137-141 |
Buy |
| Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups |
Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
|
Mar/Apr 2016 |
159-163 |
Buy |
| Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions |
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016 |
167-174 |
Buy |
| Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care |
Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
|
Jan/Feb 2016 |
58-62 |
Buy |
| A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis |
Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
|
Jan/Feb 2016 |
71-80 |
Buy |
| Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date |
Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
|
Jan/Feb 2016 |
81-85 |
Buy |
| Basic Principles of Lyophilization, Part 1 |
Akers Michael J
|
Nov/Dec 2015 |
471-476 |
Buy |
| Mixing in a Compounding Pharmacy in the 21st Century |
Standridge Rob
|
Nov/Dec 2015 |
479-484 |
Buy |
| Vehicle for Oral Solution (National Formulary 26) |
Allen Loyd V Jr
|
Sep/Oct 2015 |
411 |
Buy |
| Vehicle for Oral Solution, Sugar Free (National Formulary 26) |
Allen Loyd V Jr
|
Sep/Oct 2015 |
412 |
Buy |
| Vehicle for Oral Suspension (National Formulary 26) |
Allen Loyd V Jr
|
Sep/Oct 2015 |
413 |
Buy |
| Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules |
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015 |
414-419 |
Buy |
| Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF |
Geiger Christine M, Sorenson Bridget, Whaley Paul
|
Sep/Oct 2015 |
420-427 |
Buy |
| Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters |
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015 |
334-336 |
Buy |
| Stability of Prednisone in Oral Mix Suspending Vehicle |
Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
|
Jul/Aug 2015 |
337-339 |
Buy |
| Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes |
Anderson Collin R, Halford Zachery, MacKay Mark
|
Jul/Aug 2015 |
344-347 |
Buy |
| Basics of Compounding: Compounding with Silicones |
Allen Loyd V Jr
|
May/Jun 2015 |
223-230 |
Buy |
| Stability of Metronidazole Suspensions |
Donnelly Ronald F, Ying James
|
May/Jun 2015 |
248-251 |
Buy |
| Transdermal Delivery of Nisoldipine: Refinement of Vehicles |
El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
|
Mar/Apr 2015 |
152-160 |
Buy |
| Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations |
Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
|
Mar/Apr 2015 |
161-166 |
Buy |
| Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review |
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015 |
6-12 |
Buy |
| Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 |
Allen Loyd V Jr
|
Jan/Feb 2015 |
38-40 |
Buy |
| Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions |
Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
|
Jan/Feb 2015 |
73-77 |
Buy |
| Stability of Suspensions: Theoretical and Practical Considerations before Compounding |
Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
|
Jan/Feb 2015 |
78-85 |
Buy |
| Skin Penetration and Antinociception of Topical Gabapentin Formulations |
Bryson Evan, Asbill Scott, Sweitzer Sarah
|
Nov/Dec 2014 |
504-511 |
Buy |
| In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations |
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014 |
512-515 |
Buy |
| Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils |
Boonme Prapaporn, Maneenuan Duangkhae
|
Nov/Dec 2014 |
516-519 |
Buy |
| High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products |
Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
|
Nov/Dec 2014 |
520-525 |
Buy |
| Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition |
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014 |
427-431 |
Buy |
| Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis |
Reisacher William, Rudner Shara, Kotik Viktoriya
|
Jul/Aug 2014 |
287-290 |
Buy |
| Color Additives: Legislative Perspective in the United States, Europe, Australia, and India |
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014 |
293-300 |
Buy |
| Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging |
Allen Loyd V Jr
|
Jul/Aug 2014 |
318-319 |
Buy |
| Indigo Carmine Injection |
Allen Loyd V Jr
|
Jul/Aug 2014 |
329 |
Buy |
| Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream |
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014 |
332-340 |
Buy |
| Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding |
Hoffmann Brittany, Carlson Christie, Rao Deepa A
|
Jul/Aug 2014 |
341-344 |
Buy |
| Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date |
Peacock Gina F, Sauvageot Jurgita
|
Jul/Aug 2014 |
345-347 |
Buy |
| Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date |
Peacock Gina F, Sauvageot Jurgita, Addo Richard T
|
Jul/Aug 2014 |
348-350 |
Buy |
| Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 |
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014 |
213-221 |
Buy |
| Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams |
Allen Loyd V Jr
|
May/Jun 2014 |
228-230 |
Buy |
| Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date |
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014 |
253-255 |
Buy |
| Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery |
Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
|
May/Jun 2014 |
256-261 |
Buy |
| Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding |
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014 |
123-130 |
Buy |
| Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions |
Allen Loyd V Jr
|
Mar/Apr 2014 |
137-138 |
Buy |
| Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks |
Allen Loyd V Jr
|
Jan/Feb 2014 |
42-45 |
Buy |
| Aztreonam Injection |
Allen Loyd V Jr
|
Jan/Feb 2014 |
60 |
Buy |
| Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 |
Horace Alexis E, Akbarian-Tefagh Jessica
|
Nov/Dec 2013 |
446-450 |
Buy |
| Basics of Compounding: Basics of Compounding with Balsams |
Allen Loyd V Jr
|
Nov/Dec 2013 |
490-495 |
Buy |
| Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles |
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013 |
508-511 |
Buy |
| Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds |
Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
|
Nov/Dec 2013 |
512-514 |
Buy |
| Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream |
Wang Xuexuan, Black Laura
|
Nov/Dec 2013 |
520-525 |
Buy |
| Chemical Penetration Enhancers |
Newton Stephen J
|
Sep/Oct 2013 |
370-374 |
Buy |
| Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines |
Pruitt Bobby N III
|
Sep/Oct 2013 |
384-387 |
Buy |
| Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 |
Horace Alexis E, Akbarian-Tefagh Jessica
|
Sep/Oct 2013 |
388-391 |
Buy |
| Basics of Compounding: Basics of Compounding with Tars |
Allen Loyd V Jr
|
Sep/Oct 2013 |
400-410 |
Buy |
| In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs |
Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
|
Sep/Oct 2013 |
424-431 |
Buy |
| Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment |
Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
|
Sep/Oct 2013 |
432-435 |
Buy |
| Basics of Compounding: Foam Dosage Forms |
Allen Loyd V Jr
|
Jul/Aug 2013 |
312-322 |
Buy |
| Stability of Captopril in SyrSPend SF |
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013 |
336-338 |
Buy |
| Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry |
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013 |
344-346 |
Buy |
| Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs |
Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee
|
Jul/Aug 2013 |
347-350 |
Buy |
| Optimizing Third-party Reimbursement for Compounded Medications |
McElhiney Linda F
|
May/Jun 2013 |
201-204 |
Buy |
| Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel |
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013 |
247-253 |
Buy |
| Stability of Rifampin in SyrSpend SF |
Sorenson Bridget, Whaley Paul
|
Mar/Apr 2013 |
162-164 |
Buy |
| Stability of Minoxidil in Espumil Foam Base |
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Mar/Apr 2013 |
165-167 |
Buy |
| Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients |
Zur Eyal
|
Jan/Feb 2013 |
10-22 |
Buy |
| Stability of Ursodiol in SyrSpend SF Cherry Flavored |
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012 |
510-512 |
Buy |
| Stability of Propranolol Hydrochloride in SyrSpend SF |
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012 |
513-515 |
Buy |
| Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations |
Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
|
Nov/Dec 2012 |
516-523 |
Buy |
| Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies |
Zur Eyal
|
Sep/Oct 2012 |
386-393 |
Buy |
| Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date |
Peacock Gina F, Sauvageot Jurgita
|
Sep/Oct 2012 |
428-430 |
Buy |
| Selection of Color Additives: A Regulatory View |
Kumar Anuj, Dureja Harish, Madan Anil K
|
Jul/Aug 2012 |
304-309 |
Buy |
| Stability of Gabapentin in SyrSpend SF |
Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
|
Jul/Aug 2012 |
347-349 |
Buy |
| In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream |
Lehman Paul A, Raney Sam G
|
May/Jun 2012 |
248-252 |
Buy |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 |
Allen Loyd V Jr
|
Mar/Apr 2012 |
146-150 |
Buy |
| Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) |
Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
|
Mar/Apr 2012 |
164-166 |
Buy |
| Stability of Vancomycin in SyrSpend SF |
Whaley Paul A, Voudrie Mark A II
|
Mar/Apr 2012 |
167-169 |
Buy |
| The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs |
Bramwell Bethany L, Williams LaVonn A
|
Jan/Feb 2012 |
62-63 |
Buy |
| A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard |
Walker Heather, Sridhar Vishak, Alexander Kenneth S
|
Nov/Dec 2011 |
510-514 |
Buy |
| Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant |
Jha Antesh Kr, Chetia D
|
Nov/Dec 2011 |
521-525 |
Buy |
| Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons |
James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
|
Sep/Oct 2011 |
390-407 |
Buy |
| Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations |
Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
|
Sep/Oct 2011 |
435-437 |
Buy |
| Quality-Control Analytical Methods: Using Purified Water for Reconstitutions |
Biller Jeremy
|
Jul/Aug 2011 |
322-326 |
Buy |
| Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles |
Voudrie Mark A, Alexander Bridget, Allen D Brett
|
May/Jun 2011 |
255-258 |
Buy |
| Drug Compatibility and Stability in Dextrose vs Saline |
Newton David W
|
May/Jun 2011 |
190-192 |
Buy |
| Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions |
Schnatz Rick, Hernandex-Cardoso Antonio
|
May/Jun 2011 |
224-232 |
Buy |
| Basics of Compounding: Basics of Compounding with Complex Organic Molecules |
Allen Loyd V Jr
|
May/Jun 2011 |
234-238 |
Buy |
| Home Infusion Basics for the Non-Infusion Pharmacist |
Miron Karen E
|
Mar/Apr 2011 |
94-100 |
Buy |
| Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 |
Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
|
Mar/Apr 2011 |
133-144 |
Buy |
| Basics of Compounding: Basics of Compounding with Inorganic Salts |
Allen Loyd V Jr
|
Mar/Apr 2011 |
146-153 |
Buy |
| Oral Film Strip Vehicle |
Allen Loyd V Jr
|
Mar/Apr 2011 |
164 |
Buy |
| Maillard Reactions in Pharmaceutical Formulations and Human Health |
Newton David W
|
Jan/Feb 2011 |
32-40 |
Buy |
| Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates |
Allen Loyd V Jr
|
Nov/Dec 2010 |
508-510 |
Buy |
| Extemporaneous Compounding of Medicated Ointment |
Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
|
Nov/Dec 2010 |
472-478 |
Buy |
| Recommendations for Compounding Medications for Feeding Tube Administration |
Klang Mark
|
Jul/Aug 2010 |
276-282 |
Buy |
| Considerations for Percutaneous Absorption |
Newton Stephen J, Cook Jennifer M
|
Jul/Aug 2010 |
301-304 |
Buy |
| Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome |
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010 |
182-192 |
Buy |
| Managing Pain with Transdermal Ketoprofen |
Williams KaCee D
|
May/Jun 2010 |
204-206 |
Buy |
| Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules |
McElhiney Linda F
|
Mar/Apr 2010 |
118-123 |
Buy |
| Plasticized Hydrocarbon Gel |
Allen Loyd V Jr
|
Mar/Apr 2010 |
158 |
Buy |
| Oral Adhesive Paste |
Allen Loyd V Jr
|
Mar/Apr 2010 |
159 |
Buy |
| Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet |
McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
|
Jan/Feb 2010 |
21-25 |
Buy |
| Testosterone 1% in Alcoholic Gel |
Allen Loyd V Jr
|
Jan/Feb 2010 |
72 |
Buy |
| Hydrocarbon-Free Lotion |
Allen Loyd V Jr
|
Jan/Feb 2010 |
67 |
Buy |
| Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle |
Gupta Vishnu D
|
Jan/Feb 2010 |
76-77 |
Buy |
| Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) |
Voudrie Mark A II, Allen D Brett
|
Jan/Feb 2010 |
82-85 |
Buy |
| Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms |
Bramwell Bethany L
|
Nov/Dec 2009 |
498-505 |
Buy |
| Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis |
Mixon William, Angelle Patricea (Patsy), Chang Richard I
|
Nov/Dec 2009 |
506-515 |
Buy |
| The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel |
Arnold John J, Asbill Scott
|
Nov/Dec 2009 |
569-571 |
Buy |
| Twevan Cream |
Allen Loyd V Jr
|
Nov/Dec 2009 |
561 |
Buy |
| Recommended Tips for Treating Veterinary Patients |
Bramwell Bethany L, Williams LaVonn A
|
Sep/Oct 2009 |
390-391 |
Buy |
| Alcohol-based Carbomer Gel |
Allen Loyd V Jr
|
Jul/Aug 2009 |
332 |
Buy |
| Formulation Optimization Study for an Immediate-Release Tablet |
Kyriacos Soula, Dimassi Hani
|
May/Jun 2009 |
259-261 |
Buy |
| Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions |
Xu Meng, Warren Flynn W, Bartlett Michael G
|
Mar/Apr 2009 |
166-169 |
Buy |
| Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule |
Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
|
Mar/Apr 2009 |
170-174 |
Buy |
| Compounding for Pediatric Patients: Case Reports and Formulations |
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009 |
6-12 |
Buy |
| The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials |
Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
|
Jan/Feb 2009 |
81-86 |
Buy |
| Veterinary Compounding for Myasthenia Gravis |
Davidson Gigi S
|
Sep/Oct 2008 |
398-401 |
Buy |
| Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration |
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008 |
460-462 |
Buy |
| Excipient Choices for Special Populations |
Nagel-Edwards Karen M, Ko James Y
|
Sep/Oct 2008 |
426-430 |
Buy |
| Case Reports: Compounding to Relieve Arthritis Pain |
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008 |
498-504 |
Buy |
| Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System |
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008 |
558-564 |
Buy |
| Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting |
McElhiney Linda F
|
Jul/Aug 2008 |
316-320 |
Buy |
| Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model |
Bassani August S, Banov Daniel, Lehman Paul A
|
May/Jun 2008 |
270-273 |
Buy |
| Proteins Used as Sweeteners |
Li Xiaojian, Alexander Kenneth S
|
Nov/Dec 2007 |
476-481 |
Buy |
| Nondetergent Neutral Dry Skin Cream |
Allen Loyd V Jr
|
Sep/Oct 2007 |
425 |
Buy |
| Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion |
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007 |
426-432 |
Buy |
| Isoniazid Release from Suppositories Compounded with Selected Bases |
Hudson Kristofer C, Asbill C Scott, Webster Andrew A
|
Sep/Oct 2007 |
433-437 |
Buy |
| Vehicle N Formulas |
Allen Loyd V Jr
|
Jul/Aug 2007 |
337 |
Buy |
| Challenges of Compounding for Patients on the Ketogenic Diet |
McElhiney Linda F
|
Mar/Apr 2007 |
116-120 |
Buy |
| Including Pets in Diabetic Care |
Davidson Gigi S
|
Mar/Apr 2007 |
126-130 |
Buy |
| Oral Liquid Vehicle, Anhydrous |
Allen Loyd V Jr
|
Mar/Apr 2007 |
159 |
Buy |
| Stability of Oseltamivir in Various Extemporaneous Liquid Preparations |
Ford Stephen M, Kloesel Lawson G, Grabenstein John D
|
Mar/Apr 2007 |
164-176 |
Buy |
| Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 |
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007 |
5-8 |
Buy |
| Pediatric Oral Formulations: A Continual Challenge |
Hurtado Josephine, Moffett Brady S
|
Jan/Feb 2007 |
17-19 |
Buy |
| Application of Sildenafil for Pulmonary Hypertension in Canines and Foals |
Davidson Gigi S
|
Nov/Dec 2006 |
405-408 |
Buy |
| Compounding for Feline Herpetic Keratitis |
Davidson Gigi S
|
Nov/Dec 2006 |
411-414 |
Buy |
| In Vitro Transdermal Diffusion of Zileuton from a Topical Gel |
Bigeleisen Paul E
|
Sep/Oct 2006 |
392-395 |
Buy |
| Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together |
Gupta Vishnu D
|
May/Jun 2006 |
237-239 |
Buy |
| Extended Stability of Oxytocin in Common Infusion Solutions |
Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric
|
Mar/Apr 2006 |
156-158 |
Buy |
| Acacia and Mineral Oil Emulsion NF |
Al-Achi Antoine, Mosley Anita, Patlolla Swapna
|
Jan/Feb 2006 |
44 |
Buy |
| Medium-Chain Triglycerides Oral Vehicle, Anhydrous |
Allen Loyd V Jr
|
Jan/Feb 2006 |
63 |
Buy |
| Pediatric Oral Liquid Preparations |
Fonseca Simonne C, Ferreira Anderson de O
|
Nov/Dec 2005 |
437-442 |
Buy |
| Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions |
Fonseca Simonne C
|
Nov/Dec 2005 |
456-461 |
Buy |
| Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products |
Allen Loyd V Jr
|
Nov/Dec 2005 |
462-469 |
Buy |
| Formulating for the Gluten-sensitive Individual |
Cacace Janice L
|
Sep/Oct 2005 |
357-358 |
View Sample |
| Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration |
Landry Christine, Forest Jean-Marc, Hildgen Patrice
|
Sep/Oct 2005 |
396-298 |
Buy |
| Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion |
Gupta Vishnu D
|
Sep/Oct 2005 |
399-401 |
Buy |
| Physical characteristics of selected over-the-counter medications |
Al-Achi Antoine, Shipp Shawnte
|
Jan/Feb 2005 |
75-81 |
Buy |
| Stability of an Extemporaneously Compounded Propylthiouracil Suspension |
Alexander Kenneth S, Mitra Pallabi
|
Jan/Feb 2005 |
82-86 |
Buy |
| A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid |
McElhiney Linda F
|
Nov/Dec 2004 |
458-460 |
Buy |
| Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink |
Donnelly Ronald F
|
Nov/Dec 2004 |
489-491 |
Buy |
| Featured Excipient: Plasticizers |
Allen Loyd V Jr
|
Mar/Apr 2003 |
145-148 |
Buy |
| Featured Excipient: Flavor Enhancing Agents |
Allen Loyd V Jr
|
Jan/Feb 2003 |
48-50 |
Buy |
| Featured Excipient: Disinfecting Agents |
Allen Loyd V Jr
|
Nov/Dec 2002 |
462-464 |
Buy |
| Featured Excipient: Specially Denatured Alcohols |
Allen Loyd V Jr
|
Sep/Oct 2002 |
380-383 |
Buy |
| Topical Oil-in-Water Cream Bases, Featured Excipient: |
Allen Loyd V Jr
|
Jul/Aug 2002 |
303-304 |
Buy |
| Sorbitan Esters, Featured Excipient: |
Allen Loyd V Jr
|
May/Jun 2002 |
221-223 |
Buy |
| Polysorbates, Featured Excipient: |
Allen Loyd V Jr
|
Mar/Apr 2002 |
147-148 |
Buy |
| Poloxamers, Featured Excipient: |
Allen Loyd V Jr
|
Jan/Feb 2002 |
58-59 |
Buy |
| Tablet and Lozenge Binders, Featured Excipient: |
Allen Loyd V Jr
|
Nov/Dec 2001 |
471-473 |
Buy |
| Capsule and Tablet Disintegrating Agents, Featured Excipient: |
Allen Loyd V Jr
|
Sep/Oct 2001 |
389-390 |
Buy |
| Wetting and/or Solubilizing Agents, Featured Excipient: |
Allen Loyd V Jr
|
Jul/Aug 2001 |
310-312 |
Buy |
| Official Water-Repelling Agents: The Official Silicones, Featured Excipient: |
Allen Loyd V Jr
|
May/Jun 2001 |
228 |
Buy |
| Ointment Vehicles, Featured Excipient: |
Allen Loyd V Jr
|
Mar/Apr 2001 |
145-146 |
Buy |
| Oral Liquid Vehicles, Featured Excipient: |
Allen Loyd V Jr
|
Jan/Feb 2001 |
65-67 |
Buy |
| Oleaginous Vehicles, Featured Excipient: |
Allen Loyd V Jr
|
Nov/Dec 2000 |
470-472 |
Buy |
| Capsule and Tablet Lubricants, Featured Excipient: |
Allen Loyd V Jr
|
Sep/Oct 2000 |
390 |
Buy |
| Capsule and Tablet Diluents, Featured Excipient: |
Allen Loyd V Jr
|
Jul/Aug 2000 |
306-310 |
Buy |
| Cellulose Applications for the Pharmaceutical Industry |
Nicoll Harold
|
May/Jun 2000 |
196-197 |
Buy |
| Tonicity-Adjusting Agents, Featured Excipient: |
Allen Loyd V Jr
|
May/Jun 2000 |
218-220 |
Buy |
| Official Solvents, Featured Excipient: |
Allen Loyd V Jr
|
Mar/Apr 2000 |
139-142 |
Buy |
| Stiffening Agents, Featured Excipient: |
Allen Loyd V Jr
|
Jan/Feb 2000 |
60-62 |
Buy |
| Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient: |
Allen Loyd V Jr
|
Nov/Dec 1999 |
479 |
Buy |
| Alkalizing Agents, Featured Excipient: |
Allen Loyd V Jr
|
Sep/Oct 1999 |
404-405 |
Buy |
| Acidifying Agents, Featured Excipient: |
Allen Loyd V Jr
|
Jul/Aug 1999 |
309-310 |
Buy |
| Sweetening Agents, Featured Excipient: |
Allen Loyd V Jr
|
May/Jun 1999 |
228-231 |
Buy |
| Preservatives, Featured Excipient: |
Allen Loyd V Jr
|
Mar/Apr 1999 |
142-143 |
Buy |
| Antioxidants, Featured Excipient: |
Allen Loyd V Jr
|
Jan/Feb 1999 |
52-55 |
Buy |
| Gelatin, Featured Excipient: |
Allen Loyd V Jr
|
Nov/Dec 1998 |
450-452 |
Buy |
| Dextrose Injection and Dextrose, Featured Excipient: |
Allen Loyd V Jr
|
Sep/Oct 1998 |
372-373 |
Buy |
| Polyethylene Glycols, Featured Excipient: |
Allen Loyd V Jr
|
Jul/Aug 1998 |
306-307 |
Buy |
| Silicates: Attapulgite, Kaolin, Kieselguhr, Magnesium Trisilicate, Pumice, Talc - Featured Excipient: |
Allen Loyd V Jr
|
Mar/Apr 1998 |
162-164 |
Buy |
| Silicates: Bentonite, Magnesium Aluminum Silicate, Silica Gel and Colloidal Silicon Dioxide - , Featured Excipient: |
Allen Loyd V Jr
|
Jan/Feb 1998 |
73-74 |
Buy |
| Water, Featured Excipient: |
Allen Loyd V Jr
|
Nov/Dec 1997 |
426-427 |
Buy |
| Benzalkonium Chloride, Featured Excipient: |
Allen Loyd V Jr
|
Sep/Oct 1997 |
336-337 |
Buy |
| Poloxamer, Featured Excipient: |
Allen Loyd V Jr
|
May/Jun 1997 |
190-191 |
Buy |
| Methylcellulose, Featured Excipient: |
Allen Loyd V Jr
|
Mar/Apr 1997 |
115 |
Buy |
